Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.

Dervieux T, Meshkin B, Neri B.

Mutat Res. 2005 Jun 3;573(1-2):180-94. Review.

PMID:
15829247
2.

The contribution of pharmacogenetics to pharmacovigilance.

Bondon-Guitton E, Despas F, Becquemont L.

Therapie. 2016 Apr;71(2):223-8. doi: 10.1016/j.therap.2016.02.005. Epub 2016 Mar 3. English, French.

PMID:
27080842
3.

Update on pharmacogenetics in cancer chemotherapy.

Innocenti F, Ratain MJ.

Eur J Cancer. 2002 Mar;38(5):639-44. Review.

PMID:
11916544
4.

Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.

Donnelly JG.

Ther Drug Monit. 2004 Apr;26(2):231-5. Review.

PMID:
15228171
5.

Overview of the pharmacoeconomics of pharmacogenetics.

Dervieux T, Bala MV.

Pharmacogenomics. 2006 Dec;7(8):1175-84. Review.

PMID:
17184205
6.

Individualized drug therapy.

Daly AK.

Curr Opin Drug Discov Devel. 2007 Jan;10(1):29-36. Review.

PMID:
17265738
7.

Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?

Soh TI, Yong WP.

Ann Acad Med Singapore. 2011 Aug;40(8):350-5. Review.

8.

Pharmacogenetics and cancer chemotherapy.

Iyer L, Ratain MJ.

Eur J Cancer. 1998 Sep;34(10):1493-9. Review.

PMID:
9893619
9.

Pharmacogenetic application in personalized cancer treatment.

Kristyanto H, Utomo AR.

Acta Med Indones. 2010 Apr;42(2):109-15. Review.

10.

Pharmacogenetics in cancer treatment.

Nagasubramanian R, Innocenti F, Ratain MJ.

Annu Rev Med. 2003;54:437-52. Epub 2001 Dec 3. Review.

PMID:
12525681
11.

CYP450 pharmacogenetics for personalizing cancer therapy.

van Schaik RH.

Drug Resist Updat. 2008 Jun;11(3):77-98. doi: 10.1016/j.drup.2008.03.002. Epub 2008 May 19. Review.

PMID:
18486526
12.

[Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].

Scharplatz M, Puhan M, Steurer J, Bachmann LM.

Praxis (Bern 1994). 2004 Mar 3;93(10):359-65. Review. German.

PMID:
15052854
13.

Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.

Deeken JF, Figg WD, Bates SE, Sparreboom A.

Anticancer Drugs. 2007 Feb;18(2):111-26. Review.

PMID:
17159598
14.

A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.

Plumpton CO, Roberts D, Pirmohamed M, Hughes DA.

Pharmacoeconomics. 2016 Aug;34(8):771-93. doi: 10.1007/s40273-016-0397-9. Review.

PMID:
26984520
15.

Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.

van Aken J, Schmedders M, Feuerstein G, Kollek R.

Am J Pharmacogenomics. 2003;3(3):149-55. Review.

PMID:
12814323
16.

Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.

Roper N, Storer B, Bona R, Fang M.

J Mol Diagn. 2010 May;12(3):283-91. doi: 10.2353/jmoldx.2010.090110. Epub 2010 Mar 12.

17.

Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.

Pillans PI.

Intern Med J. 2001 Nov;31(8):476-8. Review.

PMID:
11720061
18.

Pharmacogenetic testing in psychiatry: a review of features and clinical realities.

de Leon J, Arranz MJ, Ruaño G.

Clin Lab Med. 2008 Dec;28(4):599-617. doi: 10.1016/j.cll.2008.05.003. Review.

PMID:
19059065
19.

[Prospective validation of a pharmacogenetic test: the PREDICT-1 study].

Muñoz de Benito RM, Arribas López JR.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 6:40-4. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Oct;26(8):536.

PMID:
18680695
20.

[Cancer chemotherapy and drug metabolism enzyme].

Xu F, Zhen YS, Shao RG.

Sheng Li Ke Xue Jin Zhan. 2005 Oct;36(4):295-8. Review. Chinese.

PMID:
16408765

Supplemental Content

Support Center